A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [68Ga]Ga-PSMA-11 total-body PET/CT imaging

被引:5
作者
Lv, Jing [1 ,2 ,3 ]
Yu, Haojun [1 ,2 ,3 ]
Yin, Hongyan [1 ,2 ,3 ]
Shi, Yimeng [1 ,2 ,3 ]
Shi, Hongcheng [1 ,2 ,3 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Nucl Med, 180 Fenglin Rd, Shanghai 200032, Peoples R China
[2] Fudan Univ, Nucl Med Inst, Shanghai 200032, Peoples R China
[3] Shanghai Inst Med Imaging, Shanghai 200032, Peoples R China
关键词
Ga-68]Ga-PSMA-11; False positive PET/CT imaging; Metabolic tumor volume; Radiomics; Prostate cancer; METABOLIC TUMOR VOLUME; MULTIPARAMETRIC-MRI; BIOPSY; SENSITIVITY; PREDICTION; LIGAND;
D O I
10.1007/s00259-023-06464-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose To improve the diagnostic accuracy of initial detection in patients with suspected primary prostate cancer (PCa).Methods Eighty-four patients who underwent Gallium-68-labeled prostate-specific membrane antigen ([Ga-68]Ga-PSMA-11) total-body positron emission tomography/computed tomography (PET/CT) imaging before treatment in our department were enrolled. The maximum standard uptake value (SUVmax) of the prostate (SUVmax-PSMA), liver (SUVmax-PSMA-L), and mediastinal blood pool (SUVmax-PSMA-M) was measured using [Ga-68]Ga-PSMA-11 total-body PET/CT imaging. The [Ga-68]Ga-PSMA-11 derived metabolic tumor volume (MTV), the total lesion (TLP), and the cross-sectional areas of focal concentration in the prostate (CAP) were also determined. Besides, the prostate-specific antigen (PSA) levels and the above imaging characteristics were analyzed using receiver operating characteristic curves to identify the cutoff value to improve the diagnostic accuracy of suspected PCa. Finally, a multivariate regression analysis was conducted to discover the independent predictor to improve the diagnostic accuracy on [Ga-68]Ga-PSMA-11 total-body imaging.Results There was no significant difference between the PCa and Non-PCa groups in age, height, weight, injected dose, except for the PSA levels, the SUVmax-PSMA, TLP, MTV, and CAP. Besides, the SUVmax-PSMA-T/L and SUVmax-PSMA-T/M derived from SUVmax-PSMA were both significantly different. In addition, the areas under the curve of PSA levels, SUVmax-PSMA, SUVmax-PSMA-T/L, SUVmax-PSMA-T/M, TLP, MTV, and CAP to predict PCa on [Ga-68]Ga-PSMA-11 imaging were 0.620 (95% confidence interval (CI) 0.485-0.755), 0.864 (95% CI 0.757-0.972), 0.819 (95% CI 0.704-0.935), 0.876 (95% CI 0.771-0.980), 0.845 (95% CI 0.741-0.949), 0.820 (95% CI 0.702-0.938), 0.627 (95% CI 0.499-0.754), respectively. However, a multivariate regression analysis showed that SUVmax-PSMA was an independent predictor, with a cutoff value of 11.5 and an odds ratio of 1.221.Conclusion The SUVmax-PSMA with a cutoff value of 11.5 was an independent predictor to improve the diagnostic accuracy of PCa on [Ga-68]Ga-PSMA-11 total-body imaging.
引用
收藏
页码:919 / 927
页数:9
相关论文
共 39 条
  • [1] Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience
    Afshar-Oromieh, A.
    Haberkorn, U.
    Schlemmer, H. P.
    Fenchel, M.
    Eder, M.
    Eisenhut, M.
    Hadaschik, B. A.
    Kopp-Schneider, A.
    Roethke, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (05) : 887 - 897
  • [2] Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer
    Amin, Amer
    Blazevski, Alexandar
    Thompson, James
    Scheltema, Matthijs J.
    Hofman, Michael S.
    Murphy, Declan
    Lawrentschuk, Nathan
    Sathianathen, Niranjan
    Kapoor, Jada
    Woo, Henry H.
    Chalasani, Venu
    Rasiah, Krishan
    van Leeuwen, Pim J.
    Tang, Reuben
    Cusick, Thomas
    Stricker, Phillip
    Emmett, Louise
    [J]. BJU INTERNATIONAL, 2020, 125 (04) : 515 - 524
  • [3] Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care
    Cherry, Simon R.
    Jones, Terry
    Karp, Joel S.
    Qi, Jinyi
    Moses, William W.
    Badawi, Ramsey D.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (01) : 3 - 12
  • [4] Total-body imaging: Transforming the role of positron emission tomography
    Cherry, Simon R.
    Badawi, Ramsey D.
    Karp, Joel S.
    Moses, William W.
    Price, Pat
    Jones, Terry
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (381)
  • [5] Accuracy of Multiparametric MRI for Prostate Cancer Detection: A Meta-Analysis
    de Rooij, Maarten
    Hamoen, Esther H. J.
    Futterer, Jurgen J.
    Barentsz, Jelle O.
    Rovers, Maroeska M.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 202 (02) : 343 - 351
  • [6] Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
    Eiber, Matthias
    Weirich, Gregor
    Holzapfel, Konstantin
    Souvatzoglou, Michael
    Haller, Bernhard
    Rauscher, Isabel
    Beer, Ambros J.
    Wester, Hans-Juergen
    Gschwend, Juergen
    Schwaiger, Markus
    Maurer, Tobias
    [J]. EUROPEAN UROLOGY, 2016, 70 (05) : 829 - 836
  • [7] Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
    Eiber, Matthias
    Maurer, Tobias
    Souvatzoglou, Michael
    Beer, Ambros J.
    Ruffani, Alexander
    Haller, Bernhard
    Graner, Frank-Philipp
    Kuebler, Hubert
    Haberhorn, Uwe
    Eisenhut, Michael
    Wester, Hans-Juergen
    Gschwend, Juergen E.
    Schwaiger, Markus
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (05) : 668 - 674
  • [8] The PRIMARY Score: Using Intraprostatic 68Ga-PSMA PET/CT Patterns to Optimize Prostate Cancer Diagnosis
    Emmett, Louise
    Papa, Nathan
    Buteau, James
    Ho, Bao
    Liu, Victor
    Roberts, Matthew
    Thompson, James
    Moon, Dan
    Sheehan-Dare, Gemma
    Alghazo, Omar
    Agrawal, Shikha
    Murphy, Declan
    Stricker, Phillip
    Hope, Thomas A.
    Hofman, Michael S.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (11) : 1644 - 1650
  • [9] Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial
    Fendler, Wolfgang P.
    Ferdinandus, Justin
    Czernin, Johannes
    Eiber, Matthias
    Flavell, Robert R.
    Behr, Spencer C.
    Wu, I-Wei K.
    Lawhn-Heath, Courtney
    Pampaloni, Miguel H.
    Reiter, Robert E.
    Rettig, Matthew B.
    Gartmann, Jeannine
    Murthy, Vishnu
    Slavik, Roger
    Carroll, Peter R.
    Herrmann, Ken
    Calais, Jeremie
    Hope, Thomas A.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (12) : 1793 - 1799
  • [10] 68Ga-PSMA-11 PET/MR Can Be False Positive in Normal Prostatic Tissue
    Ferraro, Daniela A.
    Rupp, Niels J.
    Donati, Olivio F.
    Messerli, Michael
    Eberli, Daniel
    Burger, Irene A.
    [J]. CLINICAL NUCLEAR MEDICINE, 2019, 44 (04) : E291 - E293